Thomson Reuters Journals are available through the BioMed Central platform and feature high quality reviews as well as paper, patent and web alerts to provide accurate and timely information on developments in drug R&D. Covering over 400 scientific meetings per year as well as the most important developments in their subject areas, the Thomson Reuters Journals provide a practical way of staying on top of the latest developments.

Current Opinion in Investigational Drugs covers the most important developments in all therapeutic areas, including:

• Anti-infectives
• Anti-inflammatory, immunologicals and biologicals
• Cardiovascular and renal
• Central and peripheral nervous system
• Endocrine and metabolics
• Oncological